 |
| Microcrystalline Cellulose Market Size |
Microcrystalline cellulose is a partially depolymerized cellulose produced from
various sources like wood pulp, cotton linters or wheat straw. It is a white,
odourless, tasteless powder that exhibits several advantages compared to other
excipients used in pharmaceuticals. These include excellent compressibility, dilution
potential, disintegration properties, stability and tableting characteristics.
The growing pharmaceutical industry worldwide has been a major driver of demand
for microcrystalline cellulose due to its extensive use as an excipient in
tablets, capsules and other dosage forms. It is used in both immediate and
extended release tablet formulations to improve tablet strength, flow and fill
weight uniformity.
The Global Microcrystalline Cellulose Market is estimated to be valued at US$ 1349.84 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period
2024 to 2030.
Key players operating in the Microcrystalline Cellulose are Thermo Fisher
Scientific, Inc., Illumina, Inc., PerkinElmer Genomics, QIAGEN, Agilent
Technologies, Inc., F. Hoffmann-La Roche Ltd, Macrogen, Inc., Abbott, PacBio,
Zymo Research Corporation, Oxford Nanopore Technologies plc, Tecan Trading AG,
Hamilton Company, ZS Genetics, Inc. LI-COR, Inc.Some of the major opportunities
in the global microcrystalline cellulose market include rising preference for
microcrystalline cellulose from nutraceuticals industry owing to its usage as
an emulsifier, stabilizer, texturizer and thickeners. The growing
pharmaceutical and nutraceutical industries in emerging economies of Asia
Pacific provide numerous growth opportunities for players in the
microcrystalline cellulose market. Increasing overseas investments by key
microcrystalline cellulose manufacturers to expand their global footprint
especially in developing regions will further aid the market expansion during
the forecast period.
Market drivers: One of the key drivers of Microcrystalline
Cellulose Market Size is the rising applications of microcrystalline
cellulose in pharmaceuticals. Microcrystalline cellulose is extensively used as
an excipient in tablets, capsules and other dosage forms. Its advantages like
excellent compressibility, dilution potential and disintegration properties
have increased its demand in pharmaceutical industry.
Market restraints: One of the key restraint for microcrystalline cellulose
market is availability of substitutes. Other excipients like starch,
pregelatinized starch, hydroxypropyl cellulose etc. act as substitutes for
microcrystalline cellulose in pharmaceutical products. These substitutes offer
similar functionalities as microcrystalline cellulose which may hamper the
market growth.
Segment Analysis
Microcrystalline Cellulose market can be segmented into pharmaceutical grade
and food grade. The pharmaceutical grade dominates the market as it finds wide
usage in the healthcare industry like as an excipient in the tablet production.
The pharmaceutical grade dominates over 80% of the overall market share owing
to its high purity and functionality benefits like excellent glidant, binding
properties and disintegration abilities in the final drug formulation.
Global Analysis
Regionally, North America dominates the overall microcrystalline cellulose
market due to well established healthcare and pharmaceutical industry in
countries like US. Europe follows North America in terms of market share due to
presence of many key market players. However, Asia Pacific is expected to grow
at the fastest rate during the forecast period owing to expansion of healthcare
sector and growing pharmaceutical industry in emerging economies of India and
China. Key players are expanding their production facilities in Asia Pacific to
tap the business opportunities offered in the region.
Get More Insights On This Topic: https://www.newsstatix.com/microcrystalline-cellulose-market-scope/